11/21/2008
Federal Register Notice: FDA has determined that Nubain (nalbuphine hydrochloride) injection, 10 and 20 mg/ml, was not withdrawn f...11/17/2008
Federal Register Notice: FDA seeks comments on reprocessed single-use device labeling, “Compliance With Section 301 of the M...11/17/2008
Federal Register Notice: FDA has determined the regulatory review period for Somatuline Depot is 3,629 days for extending a patent...10/20/2008
Federal Register Notice: FDA is making available a draft guidance, Tropical Disease Priority Review Vouchers. It explains to stake...10/17/2008
Federal Register Notice: FDA’s collection of information, “Temporary Marketing Permit Applications,” has been ap...10/15/2008
Federal Register Notice: FDA’s Circulatory System Devices Panel will meet 11/20, from 8 a.m. to 5:30 p.m. at the Gaithersbur...10/15/2008
Federal Register Notice: FDA is requesting assistance in identifying types of FDA-regulated products that contain Bisphenol A (BPA...10/15/2008
Federal Register Notice: FDA is requesting nominations for voting members to serve on the Device Good Manufacturing Practice Advis...